Literature DB >> 2893796

Secondary structure of the Neurospora crassa plasma membrane H+-ATPase as estimated by circular dichroism.

J P Hennessey1, G A Scarborough.   

Abstract

In a previous communication, a water-soluble, hexameric form of the Neurospora crassa plasma membrane H+-ATPase was described (Chadwick, C. C., Goormaghtigh, E., and Scarborough, G. A. (1987) Arch. Biochem. Biophys. 252, 348-356). To facilitate physical studies of the hexamers, the H+-ATPase isolation procedure has been improved, resulting in a structurally and functionally stable hexamer preparation that contains only 5 to 10% non-ATPase protein, approximately 12 mol of enzyme-bound lysophosphatidylcholine/mol of H+-ATPase monomer, and little or no residual plasma membrane phospholipid. Importantly, when activated by lysophosphatidylglycerol, which satisfies the acidic phospholipid requirement of the enzyme, the hexameric quaternary structure of the enzyme is retained, indicating that the functional properties of the water-soluble hexamers are relevant to those of the native, membrane-bound enzyme. The circular dichroism (CD) spectrum of this H+-ATPase preparation has been measured from 184 to 260 nm and used to estimate the secondary structure of the enzyme. The H+-ATPase is estimated to consist of approximately 36% helix, 12% antiparallel beta-sheet, 8% parallel beta-sheet, 11% beta-turn, and 26% other (irregular) structure. There is no change in the CD spectrum when known enzyme ligands are added to the H+-ATPase solution, suggesting that any changes in secondary structure that might occur during ligand binding and/or catalytic cycling are either minor or result in compensatory changes in secondary structure. The CD spectrum of the H+-ATPase is also compared to published spectra of the animal cell Na+/K+- and Ca2+-ATPases and is shown to be quite similar in shape and intensity, suggesting that all of these ATPases, which have significant sequence homology and are mechanistically similar, may have similar secondary structure composition as well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2893796

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Domain movements of plasma membrane H(+)-ATPase: 3D structures of two states by electron cryo-microscopy.

Authors:  Kyong-Hi Rhee; Gene A Scarborough; Richard Henderson
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 2.  Molecular mechanism of the P-type ATPases.

Authors:  Gene A Scarborough
Journal:  J Bioenerg Biomembr       Date:  2002-08       Impact factor: 2.945

3.  An evaluation of detergents for NMR structural studies of membrane proteins.

Authors:  Ray D Krueger-Koplin; Paul L Sorgen; Suzanne T Krueger-Koplin; Iván O Rivera-Torres; Sean M Cahill; David B Hicks; Leo Grinius; Terry A Krulwich; Mark E Girvin
Journal:  J Biomol NMR       Date:  2004-01       Impact factor: 2.835

Review 4.  Probing the structure of the Neurospora crassa plasma membrane H(+)-ATPase.

Authors:  G A Scarborough
Journal:  Mol Cell Biochem       Date:  1992-09-08       Impact factor: 3.396

5.  Interaction with lipid II induces conformational changes in bovicin HC5 structure.

Authors:  Aline Dias Paiva; Nicole Irving; Eefjan Breukink; Hilário Cuquetto Mantovani
Journal:  Antimicrob Agents Chemother       Date:  2012-06-11       Impact factor: 5.191

6.  2-D structure of the Neurospora crassa plasma membrane ATPase as determined by electron cryomicroscopy.

Authors:  M Cyrklaff; M Auer; W Kühlbrandt; G A Scarborough
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

7.  The Oligomeric State of the Plasma Membrane H⁺-ATPase from Kluyveromyces lactis.

Authors:  Yadira G Ruiz-Granados; Valentín De La Cruz-Torres; José G Sampedro
Journal:  Molecules       Date:  2019-03-08       Impact factor: 4.411

8.  Isolation of native plasma membrane H+-ATPase (Pma1p) in both the active and basal activation states.

Authors:  Jesper Torbøl Pedersen; Tamara Kanashova; Gunnar Dittmar; Michael Palmgren
Journal:  FEBS Open Bio       Date:  2018-03-25       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.